In preclinical studies, IAP0971 can stimulate the proliferation of CD8+ T cells and NKT cells, activate NK cells to kill tumor cells, and significantly inhibit tumor growth in mice at as low as 0.1 mg/kg without affecting their body weights (123). The gene discussed is CD8A; the disease is neoplasm.